Dr. Christie M. Ballantyne, professor of medicine, has been named chief of the section of cardiology in the Margaret M. and Albert B. Alkek Department of Medicine at Baylor College of Medicine.
Ballantyne has been acting interim chief since March 2009.
Along with his new position, Ballantyne will continue to serve as chief of the section of cardiovascular research, chief of the division of atherosclerosis and vascular medicine at BCM. He is also the director of the Maria and Alando J. Ballantyne, M.D., Atherosclerosis Clinical Research Laboratory and serves as the director of the Center for Cardiovascular Disease Prevention at the Methodist DeBakey Heart & Vascular Center and co-director of the Lipid Metabolism and Atherosclerosis Clinic at the Methodist Hospital.
"In his dual roles as chief of the sections of cardiology and cardiovascular research, Dr. Ballantyne is exceedingly well positioned to launch major new initiatives in translational research, clinical care, and education in the field of cardiovascular diseases at Baylor," said Dr. Robert Todd, professor and chair of the Department of Medicine at BCM.
Ballantyne, a graduate of BCM, is nationally and internationally-recognized for his basic and translational research focused on the role of inflammation and cell adhesion molecules in the pathogenesis of vascular disease. He is equally well known for his clinical research efforts to identify and characterize novel, predictive biomarkers of atherosclerotic vascular disease, and for his contributions to the development of new therapeutic strategies to prevent and combat atherosclerosis and its complications of myocardial infarction and stroke. He is also an advisory board member and director of multiple national clinical trials of novel pharmacological agents.
Ballantyne has authored more than 370 articles and is the recipient of nearly $10 million of extramural research support from federal and non-federal funding agencies. His extensive work has been honored through several local and national prestigious awards.
In addition to his research and patient care, Ballantyne is also the editor of the online journal, Lipidsonline.org, and a member of the editorial board of five international journals. Ballantyne is a member of multiple professional societies, including the American Society for Clinical Investigation.